M.D. Sass LLC’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-37,500
Closed -$6.13M 53
2017
Q4
$6.13M Sell
37,500
-175,587
-82% -$31.5M 0.55% 35
2017
Q3
$43.7M Sell
213,087
-102,178
-32% -$23.8M 3.66% 6
2017
Q2
$76.6M Buy
315,265
+28,089
+10% +$6.6M 5.01% 2
2017
Q1
$68.6M Sell
287,176
-87,825
-23% -$20.5M 3.57% 7
2016
Q4
$78.8M Buy
375,001
+40,557
+12% +$8.4M 4.43% 2
2016
Q3
$77M Sell
334,444
-19,735
-6% -$4.82M 4.35% 6
2016
Q2
$81.8M Buy
354,179
+87,771
+33% +$20.2M 4% 7
2016
Q1
$71.4M Buy
266,408
+28,480
+12% +$8.15M 3.83% 10
2015
Q4
$74.4M Sell
237,928
-18,046
-7% -$5.37M 4.07% 5
2015
Q3
$69.6M Sell
255,974
-34,444
-12% -$10.6M 3.84% 8
2015
Q2
$88.1M Buy
290,418
+6,638
+2% +$1.98M 4.39% 2
2015
Q1
$84.5M Sell
283,780
-34,883
-11% -$9.95M 4.29% 6
2014
Q4
$82M Buy
318,663
+103,263
+48% +$25.8M 5.06% 4
2014
Q3
$52M Sell
215,400
-117,810
-35% -$26.4M 3.02% 14
2014
Q2
$74.3M Buy
333,210
+24,420
+8% +$5.06M 4.41% 7
2014
Q1
$63.6M Buy
308,790
+8,100
+3% +$1.6M 4.09% 7
2013
Q4
$50.5M Sell
300,690
-119,400
-28% -$18.7M 3.59% 10
2013
Q3
$60.5M Sell
420,090
-5,050
-1% -$673K 4.77% 2
2013
Q2
$53.7M Buy
+425,140
New +$48.1M 4.41% 1

Other funds holding AGN

M.D. Sass LLC's AGN Position: Q1 2018 in Review

M.D. Sass LLC sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 37,500 shares — an estimated $6.13M sold.

M.D. Sass LLC first reported a position in AGN in Q2 2013 and held it in 19 quarters. The position peaked at $88.1M in Q2 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • M.D. Sass LLC reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • M.D. Sass LLC sold 37,500 Allergan plc shares in Q1 2018, an estimated $6.13M.
  • M.D. Sass LLC first reported a position in Allergan plc in Q2 2013 and held it in 19 quarters.
  • M.D. Sass LLC's Allergan plc position peaked at $88.1M in Q2 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on M.D. Sass LLC's 13F filing for Q1 2018, filed 14 May 2018.